Skip to main content
Clinical Trials/NCT02606071
NCT02606071
Unknown
Not Applicable

Italian Registry On Multipoint Left Ventricular

University of Rome Tor Vergata3 sites in 1 country436 target enrollmentAugust 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
University of Rome Tor Vergata
Enrollment
436
Locations
3
Primary Endpoint
Left ventricular ejection fraction
Last Updated
8 years ago

Overview

Brief Summary

The IRON-MPP is a prospective multicenter, observational registry designed to collect clinical and device data from a large cohort of HF patients treated in clinical practice with a CRT-D device with the ability to deliver Multi Point Pacing.

The purpose of the Registry is to collect data on how MPP-devices are being used by physicians in order to better understand how to improve the clinical care of patients and effectiveness of MPP therapy.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
September 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Rome Tor Vergata
Responsible Party
Principal Investigator
Principal Investigator

Giovanni B Forleo

MD

Luigi Sacco University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients implanted with a St. Jude Medical CRT-D system with MPP capability

Exclusion Criteria

  • Patients currently participating in any other clinical investigation

Outcomes

Primary Outcomes

Left ventricular ejection fraction

Time Frame: 6 Months

Changes in Left ventricular ejection fraction

Secondary Outcomes

  • Heart Failure Hospitalizations(12 months)
  • Appropriate device interventions(12 months)
  • Echocardiographic changes(12 months)
  • QRS Duration(Baseline and six months)

Study Sites (3)

Loading locations...

Similar Trials